1267 - HBA1c Test for the Diagnosis of Diabetes Mellitus

Page last updated: 12 October 2016

Application Detail



Description of Medical Service

The proposal relates to a new item on the Medicare Benefits Schedule (MBS). HbA1c testing for management of established diabetes is currently reimbursed through the MBS (MBS items 66551 and 66554). This proposal relates to using the same test as a diagnostic tool for diabetes mellitus, in patients with previously undiagnosed diabetes.

Description of Medical Condition

The disease relevant to the proposed medical service is diabetes mellitus, PDF Version Assessment Report (PDF 5243 KB)essentially Type II diabetes. Diabetes is a common chronic disease in Australia and contributes to mortality and morbidity. Diabetes may affect up to 8% of people between the ages of 25-75 years of age. Early diagnosis is important as effective therapy can reduce the complications associated with this disorder. These complications include eye disease leading to blindness, kidney disease which may require dialysis, ulceration and gangrene of the lower limbs that may require an amputation and an increase rate of myocardial infarction and stroke.

Reason for Application


Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

13-14 December 2012
Final Protocol (PDF 833 KB)
Final Protocol (Word 17958 KB)

Assessment Report

Contracted Assessment Report (PDF 4204 KB)
Contracted Assessment Report (Word 5148 KB)

Public Summary Document

Public Summary Document (PDF 66 KB)
Public Summary Document (Word 82 KB)

Meetings for this Application


16 - 17 August 2012
13 - 14 December 2012


12 - 13 June 2014


3 - 4 April 2014